{"id":"W4389222216","doi":"10.1182/blood-2023-173420","title":"Patient Characteristics, Treatment Patterns, and Health Outcomes in a Real-World Population of Patients with Myelofibrosis Treated with Fedratinib","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Swedish Orphan Biovitrum; Eisai; Gilead Sciences; Bristol-Myers Squibb","keywords":"Medicine; Myelofibrosis; Ruxolitinib; Discontinuation; Myeloproliferative neoplasm; Population; Constitutional symptoms; Internal medicine; Pediatrics; Anemia; International Prognostic Scoring System; Bone marrow; Myelodysplastic syndromes; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005925001,0.0001244163,0.0002833558,0.0007598157,0.0004820994,0.0007820365,0.0002406587,0.0003955116,0.001368748],"category_scores_gemma":[0.002279766,0.0001333063,0.0002467838,0.001253009,0.0003949147,0.0006058516,0.0004086383,0.0004254514,0.0002020156],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005832207,"about_ca_system_score_gemma":0.0005235855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005966994,"about_ca_topic_score_gemma":0.006832165,"domain_scores_codex":[0.9993203,0.0001663883,0.0001144733,0.0001519271,0.0001225484,0.000124384],"domain_scores_gemma":[0.9979818,0.0003081155,0.001098947,0.00006254089,0.0001841643,0.0003643943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006286733,0.00003813434,0.9988719,0.000006019619,0.00001393868,0.0001081499,0.00009139346,0.00002542782,0.0000610562,0.00001174615,0.0001037513,0.0006055791],"study_design_scores_gemma":[0.00001338326,0.0001970112,0.9975794,0.00001075029,0.00001324547,0.0009213266,0.0007378532,0.000177718,0.00003516544,0.00001755329,0.0002905937,0.000005886214],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989358,0.0001417056,0.00002571058,0.0001041524,0.000002558177,0.00001046005,0.0004095497,0.000001636022,0.000368616],"genre_scores_gemma":[0.9993623,0.00007798531,0.00004000688,0.00007682131,0.000007055703,0.00001066883,0.0003779258,8.437145e-7,0.00004647448],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005966994,"threshold_uncertainty_score":0.01186454,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02051936520654098,"score_gpt":0.2810373668516372,"score_spread":0.2605180016450962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}